372 related articles for article (PubMed ID: 26718844)
21. Discovery of novel lead in the group of N-substituted piperazine ether derivatives with potential histamine H3 receptor activity.
Kuder KJ; Stachnik M; Schunack W; Szymańska E; Kieć-Kononowicz K
Med Chem; 2014; 10(6):588-99. PubMed ID: 24047214
[TBL] [Abstract][Full Text] [Related]
22. A bioinformatics search for selective histamine h4 receptor antagonists through structure-based virtual screening strategies.
Christopher F; Thangam EB; Suresh MX
Chem Biol Drug Des; 2012 May; 79(5):749-59. PubMed ID: 22260722
[TBL] [Abstract][Full Text] [Related]
23. Delineating the role of histamine-1- and -4-receptors in a mouse model of Th2-dependent antigen-specific skin inflammation.
Mahapatra S; Albrecht M; Behrens B; Jirmo A; Behrens G; Hartwig C; Neumann D; Raap U; Bähre H; Herrick C; Dittrich AM
PLoS One; 2014; 9(2):e87296. PubMed ID: 24503582
[TBL] [Abstract][Full Text] [Related]
24. Molecular pharmacology of histamine H4 receptors.
Nijmeijer S; de Graaf C; Leurs R; Vischer HF
Front Biosci (Landmark Ed); 2012 Jun; 17(6):2089-106. PubMed ID: 22652766
[TBL] [Abstract][Full Text] [Related]
25. Profiling of histamine H4 receptor agonists in native human monocytes.
Gschwandtner M; Koether B; Werfel T; Stark H; Gutzmer R
Br J Pharmacol; 2013 Sep; 170(1):136-43. PubMed ID: 23638754
[TBL] [Abstract][Full Text] [Related]
26. Histamine H4 receptor ligands and their potential therapeutic applications.
Kiss R; Keseru GM
Expert Opin Ther Pat; 2009 Feb; 19(2):119-35. PubMed ID: 19441913
[TBL] [Abstract][Full Text] [Related]
27. Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells.
Gutzmer R; Diestel C; Mommert S; Köther B; Stark H; Wittmann M; Werfel T
J Immunol; 2005 May; 174(9):5224-32. PubMed ID: 15843518
[TBL] [Abstract][Full Text] [Related]
28. Structural insights into the agonists binding and receptor selectivity of human histamine H
Im D; Kishikawa JI; Shiimura Y; Hisano H; Ito A; Fujita-Fujiharu Y; Sugita Y; Noda T; Kato T; Asada H; Iwata S
Nat Commun; 2023 Oct; 14(1):6538. PubMed ID: 37863901
[TBL] [Abstract][Full Text] [Related]
29. A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: comparison of hERG binding and target residence time with PF-3893787.
Andaloussi M; Lim HD; van der Meer T; Sijm M; Poulie CB; de Esch IJ; Leurs R; Smits RA
Bioorg Med Chem Lett; 2013 May; 23(9):2663-70. PubMed ID: 23558237
[TBL] [Abstract][Full Text] [Related]
30. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.
Kiss R; Kiss B; Könczöl A; Szalai F; Jelinek I; László V; Noszál B; Falus A; Keseru GM
J Med Chem; 2008 Jun; 51(11):3145-53. PubMed ID: 18459760
[TBL] [Abstract][Full Text] [Related]
31. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.
Sadek B; Elz S; Pertz HH; Stark H; Schunack W
Inflamm Res; 2004 Aug; 53 Suppl 2():S109-15. PubMed ID: 15338060
[TBL] [Abstract][Full Text] [Related]
32. Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.
Geyer R; Nordemann U; Strasser A; Wittmann HJ; Buschauer A
J Med Chem; 2016 Apr; 59(7):3452-70. PubMed ID: 27007611
[TBL] [Abstract][Full Text] [Related]
33. N (α)-Methylated phenylhistamines exhibit affinity to the hH(4)R-a pharmacological and molecular modelling study.
Wittmann HJ; Elz S; Seifert R; Straber A
Naunyn Schmiedebergs Arch Pharmacol; 2011 Sep; 384(3):287-99. PubMed ID: 21800095
[TBL] [Abstract][Full Text] [Related]
34. 2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization.
Sander K; Kottke T; Tanrikulu Y; Proschak E; Weizel L; Schneider EH; Seifert R; Schneider G; Stark H
Bioorg Med Chem; 2009 Oct; 17(20):7186-96. PubMed ID: 19773175
[TBL] [Abstract][Full Text] [Related]
35. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus.
Dunford PJ; Williams KN; Desai PJ; Karlsson L; McQueen D; Thurmond RL
J Allergy Clin Immunol; 2007 Jan; 119(1):176-83. PubMed ID: 17208599
[TBL] [Abstract][Full Text] [Related]
36. Structural basis of ligand recognition and design of antihistamines targeting histamine H
Xia R; Shi S; Xu Z; Vischer HF; Windhorst AD; Qian Y; Duan Y; Liang J; Chen K; Zhang A; Guo C; Leurs R; He Y
Nat Commun; 2024 Mar; 15(1):2493. PubMed ID: 38509098
[TBL] [Abstract][Full Text] [Related]
37. Histamine receptor subtypes: a century of rational drug design.
Walter M; Stark H
Front Biosci (Schol Ed); 2012 Jan; 4(2):461-88. PubMed ID: 22202071
[TBL] [Abstract][Full Text] [Related]
38. Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands.
Savall BM; Edwards JP; Venable JD; Buzard DJ; Thurmond R; Hack M; McGovern P
Bioorg Med Chem Lett; 2010 Jun; 20(11):3367-71. PubMed ID: 20452213
[TBL] [Abstract][Full Text] [Related]
39. Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 98(3.36) of the human histamine H₄ receptor.
Nijmeijer S; Engelhardt H; Schultes S; van de Stolpe AC; Lusink V; de Graaf C; Wijtmans M; Haaksma EE; de Esch IJ; Stachurski K; Vischer HF; Leurs R
Br J Pharmacol; 2013 Sep; 170(1):89-100. PubMed ID: 23347159
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of histamine H1 and H4 receptors suggests disturbance of local regulation in human colorectal tumours by histamine.
Boer K; Helinger E; Helinger A; Pocza P; Pos Z; Demeter P; Baranyai Z; Dede K; Darvas Z; Falus A
Eur J Cell Biol; 2008 Apr; 87(4):227-36. PubMed ID: 18258331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
